Cite
HARVARD Citation
Verstockt, B. et al. (n.d.). P042 Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis. Journal of Crohn's and colitis. p. S113. [Online].